Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (81-90 of 218) with videos related to

Pageof 22
Sort By:
Environmental Health Perspectives|February 3, 2005
Chlorpyrifos accumulation patterns for child-accessible surfaces and objects and urinary metabolite excretion by children for 2 weeks after crack-and-crevice applicationParomita Hore, Mark Robson, Natalie Freeman, et al.
International Journal of Cancer|March 27, 2023
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trialElżbieta Senkus, Suzette Delaloge, Susan M Domchek, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2019
Toward automation of germline variant curation in clinical cancer geneticsVignesh Ravichandran, Zarina Shameer, Yelena Kemel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriersLauren Scheuer, Noah Kauff, Mark Robson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 22, 2019
Correction: Toward automation of germline variant curation in clinical cancer geneticsVignesh Ravichandran, Zarina Shameer, Yelena Kemel, et al.
Breast Cancer Research and Treatment|May 31, 2019
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapyMelissa Krystel-Whittemore, Jin Xu, Edi Brogi, et al.
Cancers|October 26, 2024
Development of an MRI Radiomic Machine-Learning Model to Predict Triple-Negative Breast Cancer Based on Fibroglandular Tissue of the Contralateral Unaffected Breast in Breast Cancer PatientsRoberto Lo Gullo, Rosa Elena Ochoa-Albiztegui, Jayasree Chakraborty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancerMonica N Fornier, Andrew D Seidman, Diana Lake, et al.
Journal of the American Medical Informatics Association : JAMIA|July 28, 2025
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncologyTony K W Hung, Jun J Mao, Alan L Ho, et al.
JCO Precision Oncology|September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Pageof 22

Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Environmental Health Perspectives|February 3, 2005
Chlorpyrifos accumulation patterns for child-accessible surfaces and objects and urinary metabolite excretion by children for 2 weeks after crack-and-crevice applicationParomita Hore, Mark Robson, Natalie Freeman, et al.
International Journal of Cancer|March 27, 2023
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trialElżbieta Senkus, Suzette Delaloge, Susan M Domchek, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 22, 2019
Toward automation of germline variant curation in clinical cancer geneticsVignesh Ravichandran, Zarina Shameer, Yelena Kemel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2002
Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriersLauren Scheuer, Noah Kauff, Mark Robson, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 22, 2019
Correction: Toward automation of germline variant curation in clinical cancer geneticsVignesh Ravichandran, Zarina Shameer, Yelena Kemel, et al.
Breast Cancer Research and Treatment|May 31, 2019
Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapyMelissa Krystel-Whittemore, Jin Xu, Edi Brogi, et al.
Cancers|October 26, 2024
Development of an MRI Radiomic Machine-Learning Model to Predict Triple-Negative Breast Cancer Based on Fibroglandular Tissue of the Contralateral Unaffected Breast in Breast Cancer PatientsRoberto Lo Gullo, Rosa Elena Ochoa-Albiztegui, Jayasree Chakraborty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancerMonica N Fornier, Andrew D Seidman, Diana Lake, et al.
Journal of the American Medical Informatics Association : JAMIA|July 28, 2025
Real-world evaluation of user engagement with an artificial intelligence-powered clinical trial application in oncologyTony K W Hung, Jun J Mao, Alan L Ho, et al.
JCO Precision Oncology|September 11, 2020
Predicting Expected Absolute Chemotherapy Treatment Benefit in Women With Early-Stage Breast Cancer Using EndoPredict, an Integrated 12-Gene Clinicomolecular AssayHatem Soliman, Darl D Flake, Anthony Magliocco, et al.
Pageof 22